The following is a review of developments affecting health care in CanadaThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.
The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Healthcare in Canada - February 2000
British Columbia's Ministry of Health is expanding the provincial telemedicine program. It's a three-pronged approach, modeled on the current Partnerships for Better Health program involving self-care and telecare. A nursing call centre, staffed by registered nurses, will be situated in the Lower Mainland and provide around-the-clock information. As well, a 30,000-page Web site will be set up to offer more detailed information. The project will cost about $10 million to run in its first year and is slated to begin fall 2000. As a first step in expanding telehealth services, B.C. Children's and Women's Hospital has forged a partnership with Quebec-based CIFRA Medical Inc., a Canadian technology company.
MDS Laboratories has launched a new Website, COL-LAB-ORATE (www.mdscollaborate.com) that provides diagnostic testing information that can help doctors and their patients better diagnose, monitor and possibly prevent medical conditions such as heart disease, stomach ulcers, prostate cancer, osteoporosis, male menopause and malabsorption. Initially, the program will consist of information on seven tests including: urea breath test, homocysteine test, NTx, Dpd, Malitest for the evaluation of patients with suspected malabsorption or maldigestion, PSA ratio test, and bioavailable testosterone.
Phoenix International Life Sciences Inc. and MDS Inc. have entered negotiations to merge their contract research businesses, a move that MDS said "would make it the fifth-largest contract research organization in the world." Under terms of the deal, MDS is offering to buy all of Phoenix's shares for either $16 cash or 0.4 of an MDS share. Phoenix, which said it employs more than 2,200 people, is a world leader in early-stage pharmaceutical development and is moving into late-stage pharmaceutical development. MDS has 8,500 employees, $1.2 billion revenue 1999 (CRO rev = $170 million).
Healthcare in Canada
- January 2000
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links
Send mail to email@example.com with questions or comments about this web site.
Concept and Design Blue Page
Last modified: March 2, 2000